Next Financial Group’s ARK Genomic Revolution ETF ARKG Stock Holding History

Next Financial Group’s Portfolio ARKG Stock Details ARKG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	$236K	Sell	3,842 -17,913	-82%	-$1.24M	0.02%	829
2021 Q3	$1.63M	Buy	21,755 +490	+2%	+$41.1K	0.13%	181
2021 Q2	$1.97M	Buy	21,265 +2,031	+11%	+$173K	0.16%	146
2021 Q1	$1.71M	Sell	19,234 -66	-0.3%	-$6.55K	0.15%	150
2020 Q4	$1.8M	Sell	19,300 -349	-2%	-$27.8K	0.17%	131
2020 Q3	$1.25M	Buy	+19,649	New	+$1.15M	0.13%	162
2020 Q1	–	Sell	-7,906	Closed	-$265K	–	2112
2019 Q4	$265K	Sell	7,906 -1,821	-19%	-$57.9K	0.03%	585
2019 Q3	$287K	Buy	9,727 +2,669	+38%	+$86.8K	0.03%	514
2019 Q2	$243K	Buy	+7,058	New	+$226K	0.03%	588

Other funds holding ARKG

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Next Financial Group's ARKG Position: Q4 2021 in Review

Next Financial Group reduced its ARK Genomic Revolution ETF (ARKG) stake by 82% in Q4 2021, selling an estimated $1.24M and leaving 3,842 shares worth $236K. The position accounts for 0.02% of the portfolio, ranked #829.

Next Financial Group first reported a position in ARKG in Q2 2019 and has held it in 9 quarters since. The position peaked at $1.97M in Q2 2021. 460 funds tracked by Wall St. Rank hold ARKG as of Q4 2021.

Next Financial Group held 3,842 shares of ARK Genomic Revolution ETF worth $236K as of Q4 2021.
Next Financial Group sold 17,913 ARK Genomic Revolution ETF shares in Q4 2021, an estimated $1.24M.
ARK Genomic Revolution ETF made up 0.02% of Next Financial Group's portfolio in Q4 2021, its #829 holding.
Next Financial Group first reported a position in ARK Genomic Revolution ETF in Q2 2019 and has held it in 9 quarters since.
Next Financial Group's ARK Genomic Revolution ETF position peaked at $1.97M in Q2 2021.
460 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q4 2021.

Based on Next Financial Group's 13F filing for Q4 2021, filed 15 Feb 2022.